Paper Details
- Home
- Paper Details
Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review.
Author: MacKenzieMary J, ShimKatharine, WinquistEric
Original Abstract of the Article :
Non-traumatic osteonecrosis of bone is recognized as a potential complication in solid-tumour cancer patients receiving treatment with cytotoxic chemotherapy. This review summarizes recent reports of osteonecrosis associated with chemotherapy in cancer patients, and describes the possible underlying...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2165/00002018-200831050-00001
データ提供:米国国立医学図書館(NLM)
Chemotherapy-Associated Osteonecrosis in Cancer Patients
The journey of cancer treatment can be challenging, like a camel traversing a treacherous desert landscape. This research focuses on a potentially serious complication of chemotherapy, osteonecrosis, a condition where bone tissue dies. The authors conducted a systematic review of reported cases of chemotherapy-associated osteonecrosis in patients with solid tumors. They aimed to understand the risk factors, potential mechanisms, and management strategies for this debilitating complication.
Risk Factors for Osteonecrosis
The study found that osteonecrosis was most commonly observed in men receiving chemotherapy for testicular cancer. Corticosteroid use, involvement of the femoral head, and a delayed onset of osteonecrosis were also identified as risk factors. These findings highlight the importance of early identification and preventative measures to minimize the risk of osteonecrosis in patients undergoing chemotherapy.
Implications for Cancer Treatment and Bone Health
This research underscores the importance of monitoring bone health in cancer patients receiving chemotherapy, especially those at higher risk. Early identification and prompt treatment can help to minimize the long-term consequences of osteonecrosis, such as joint pain, mobility limitations, and potential need for joint replacement. The study highlights the need for a comprehensive approach to cancer care, considering not only the tumor but also the potential impact of treatment on other organ systems, including bone health. Just as a camel needs to protect its legs during a desert journey, patients undergoing chemotherapy require careful attention to bone health.
Dr.Camel's Conclusion
This research provides valuable insights into a potentially serious complication of chemotherapy, osteonecrosis. Early identification, risk factor assessment, and preventative measures are crucial for minimizing the impact of this condition on cancer patients. The study underscores the importance of a holistic approach to cancer care, considering the long-term consequences of treatment on various organ systems.
Date :
- Date Completed 2008-09-19
- Date Revised 2021-10-20
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.